Suppliers / Mega Fine Pharma

Mega Fine Pharma

India reconciled across 2 public records · 1 entities Updated 9 July 2026

Mega Fine Pharma is an API manufacturer based in India. It holds 5 valid CEPs across a filed portfolio of 5 molecules. Its GMP standing is certified by EMA.

0
active US DMFs
5
valid CEPs
3
registered plants
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Mumbai, India Not on file
Nashik, India Not on file
Vapi, India Not on file

What they file, and where

Molecule Regulators Docs
Donepezil EDQM 1
Quetiapine EDQM 1
Rivaroxaban EDQM 1
Solifenacin Succinate EDQM 1
Teriflunomide EDQM 1

Also appears on these molecule pages

Teriflunomide API Quetiapine API Rivaroxaban API Solifenacin API Donepezil API

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA None 2

Comparing suppliers?

Choose your molecules and target markets. Mega Fine Pharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates